Format

Send to

Choose Destination
Am J Surg. 2020 Mar;219(3):509-512. doi: 10.1016/j.amjsurg.2019.08.006. Epub 2019 Aug 13.

The morbidity of C. difficile in necrotizing pancreatitis.

Author information

1
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
2
Indiana University School of Medicine, Indianapolis, IN, USA.
3
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: nzyromsk@iupui.edu.

Abstract

INTRODUCTION:

Necrotizing pancreatitis (NP) patients commonly require antibiotic treatment during the several month-long disease course. We hypothesized that Clostridium difficile infection (CDI) is common in NP and significantly impacts outcomes.

MATERIALS AND METHODS:

Retrospective review of 704 NP patients treated at a single-institution (2005-2018).

RESULTS:

10% (67/704) of patients developed CDI a mean 78 days after NP onset. Patients developing CDI experienced increased total hospital days (CDI, 104; No CDI, 42; P < 0.001), readmission rates (CDI, 85%; No CDI, 64%; P = 0.006), and duration of NP (CDI, 248 days; No CDI, 183; P = 0.001). Risk factors for CDI included antibiotic use (OR, 96.2; 95% CI, 5.9-1556.2; P = 0.001) and any organ failure (OR, 2.0; 95% CI, 1.2-3.3, P = 0.008). Mortality was not affected by CDI (CDI, 10%; No CDI, 9%; P = 0.7).

CONCLUSION:

Clostridium difficile infection is common in necrotizing pancreatitis and negatively impacts morbidity and disease recovery.

KEYWORDS:

Antibiotics; Clostridium difficile infection; Colitis; Infectious diarrhea; Necrotizing pancreatitis

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center